Short-term results of opening heart arteries in acute heart failure
Part of Heart & circulation clinical trials.
This trial looks at how well a heart procedure called PCI (which opens blocked arteries) works in people who also have acute heart failure. It helps patients understand short-term outcomes and may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with acute heart failure.
- You are having or have had a procedure to open blocked heart arteries (called PCI).
- You have not had a certain type of heart attack called NSTEMI.
- You do not have end-stage kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a structured cardiac rehabilitation program improves how well the heart recovers after a heart attack treated with a stent. It may help strengthen your heart and reduce future heart problems.
This trial compares different ways to treat serious heart artery blockages in people with a recent heart attack or unstable chest pain. It aims to see which revascularization approach works best when doctors think the heart arteries can be fully treated.
This trial looks at how a procedure to open a long-clogged heart artery (called PCI) affects patients' long-term health. If you have had a complete blockage in a heart artery but no recent major heart attack, bypass surgery, or cancer, you may be able to join.
This study tests whether opening blocked heart arteries with stents can improve heart function in people with heart failure caused by coronary artery disease. It may be an option if your heart is weak and you have multiple blockages but no recent heart attack or dangerous rhythm.
This study compares two ways of deciding how completely to open blocked heart arteries using drug-eluting stents. It aims to see which guidance approach improves results and safety for people with coronary artery disease who need a PCI (heart catheter procedure).
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
Hear when a new Primary Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.